BRCA2 and invasive breast carcinoma: Rodriguez-Pinilla et al. [16] detected fascin expression in 25.1% of sporadic invasive breast carcinomas and in 83.3% and 16.7% BRCA1- and BRCA2-associated carcinomas, respectively.